-
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1457-62
PMID: 16432223
-
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.
Nat Med. 2010 May;16(5):571-9, 1p following 579
PMID: 20436485
-
Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
Blood. 2000 Aug 1;96(3):785-93
PMID: 10910888
-
Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
Mol Ther. 2004 Nov;10(5):874-81
PMID: 15509505
-
Peaceful coexistence or clonal dominance?
Blood. 2009 Oct 22;114(17):3507-8
PMID: 19850747
-
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.
Nat Med. 2010 Feb;16(2):198-204
PMID: 20098431
-
Occurrence of leukaemia following gene therapy of X-linked SCID.
Nat Rev Cancer. 2003 Jul;3(7):477-88
PMID: 12835668
-
Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.
Nat Immunol. 2006 Feb;7(2):207-15
PMID: 16369535
-
A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications.
Nat Biotechnol. 2002 Jan;20(1):87-90
PMID: 11753368
-
NPM-ALK oncogenic tyrosine kinase controls T-cell identity by transcriptional regulation and epigenetic silencing in lymphoma cells.
Cancer Res. 2009 Nov 15;69(22):8611-9
PMID: 19887607
-
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
N Engl J Med. 2003 Jan 16;348(3):255-6
PMID: 12529469
-
Regulation of CD27 expression on subsets of mature T-lymphocytes.
J Immunol. 1993 Sep 1;151(5):2426-35
PMID: 7689607
-
Bcl-2 overexpression enhances tumor-specific T-cell survival.
Cancer Res. 2005 Mar 1;65(5):2001-8
PMID: 15753400
-
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Science. 2003 Oct 17;302(5644):415-9
PMID: 14564000
-
Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis.
Mol Ther. 2009 Sep;17(9):1537-47
PMID: 19532134
-
Murine leukemia induced by retroviral gene marking.
Science. 2002 Apr 19;296(5567):497
PMID: 11964471
-
Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis.
Blood. 2005 Jun 1;105(11):4235-46
PMID: 15713797
-
Focus on acute leukemias.
Cancer Cell. 2002 Jun;1(5):417-20
PMID: 12124171
-
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
J Clin Invest. 2008 Sep;118(9):3132-42
PMID: 18688285
-
Fatal leukemia in interleukin-15 transgenic mice.
Blood Cells Mol Dis. 2001 Jan-Feb;27(1):223-30
PMID: 11358383
-
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Cell. 2006 Aug 25;126(4):663-76
PMID: 16904174
-
Gene therapy targeting hematopoietic cells: better not leave it to chance.
Acta Haematol. 2003;110(2-3):107-9
PMID: 14583670
-
Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro.
Nat Immunol. 2004 Apr;5(4):410-7
PMID: 15034575
-
Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.
Immunity. 1995 Oct;3(4):521-30
PMID: 7584142
-
IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation.
Immunity. 1998 Nov;9(5):669-76
PMID: 9846488
-
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.
J Clin Invest. 2008 Sep;118(9):3143-50
PMID: 18688286
-
Rules for making human tumor cells.
N Engl J Med. 2002 Nov 14;347(20):1593-603
PMID: 12432047
-
Resistance of mature T cells to oncogene transformation.
Blood. 2008 Sep 15;112(6):2278-86
PMID: 18566328
-
A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
Mol Ther. 2002 Jun;5(6):788-97
PMID: 12027564
-
Interleukin-2: inception, impact, and implications.
Science. 1988 May 27;240(4856):1169-76
PMID: 3131876
-
Spectratype/immunoscope analysis of the expressed TCR repertoire.
Curr Protoc Immunol. 2001 May;Chapter 10:10.28.1-10.28.24
PMID: 18432693
-
Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.
Blood. 2000 Jul 15;96(2):467-74
PMID: 10887107
-
An improved cyan fluorescent protein variant useful for FRET.
Nat Biotechnol. 2004 Apr;22(4):445-9
PMID: 14990965
-
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene.
Blood. 2007 Jun 15;109(12):5168-77
PMID: 17353346
-
Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies.
J Immunother. 2004 Sep-Oct;27(5):405-18
PMID: 15314550
-
Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.
Hum Gene Ther. 2001 May 1;12(7):743-9
PMID: 11339891
-
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007 Nov 30;131(5):861-72
PMID: 18035408
-
Transcription start regions in the human genome are favored targets for MLV integration.
Science. 2003 Jun 13;300(5626):1749-51
PMID: 12805549
-
Gene therapy: therapeutic gene causing lymphoma.
Nature. 2006 Apr 27;440(7088):1123
PMID: 16641981